Skip to main content
CriticalFDAfda-F-1886-2013UNDECLARED ALLERGEN

40-Clove Garlic Chicken Braising Base, 24.5oz, 12 jars/case

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Units Affected
3,000
Recall Date
August 28, 2013
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1886-2013.

Premier Foods is recalling Williams-Sonoma flavored sauces due to undeclared milk and wheat allergens.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1886-2013.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Premier Foods, Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1886-2013.

Premier Foods, LLC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Premier Foods, Llc Recall FAQ

Premier Foods, Llc is the subject of a meat & poultry safety report: 40-Clove Garlic Chicken Braising Base, 24.5oz, 12 jars/case. The notice was published on August 28, 2013 by the U.S. Food and Drug Administration (FDA). Approximately 3,000 units are potentially affected.